Results 141 to 150 of about 301,386 (199)

LMP7-Specific Inhibitor M3258 Modulates the Tumor Microenvironment of Triple-Negative Breast Cancer and Inflammatory Breast Cancer. [PDF]

Cancers (Basel)
Xie X, Lee J, Manyam GC, Pearson T, Walter-Bausch G, Friese-Hamim M, Zhao S, Jabs J, Manginelli AA, Piske N, Mrowiec T, Wolf CM, Kuntal BS, Tripathy D, Wang J, Sanderson MP, Ueno NT.   +16 more
europepmc   +1 more source

Trends in Guideline-Concordant Care for Inflammatory Breast Cancer.

JAMA Netw Open
Tadros A, Diskin B, Sevilimedu V, Xu A, Vingan P, Nelson J, Iwai Y, Morrow M, Fayanju OM.   +8 more
europepmc   +1 more source

Use of natural language processing to identify patients with inflammatory breast cancer across a health-care system. [PDF]

JNCI Cancer Spectr
Kouzy R, Kai M, Le-Petross HT, Saleem S, MDACC Inflammatory Breast Cancer Team , Woodward WA.   +5 more
europepmc   +1 more source

National trends and survival outcomes associated with non-guideline-concordant treatment of inflammatory breast cancer. [PDF]

Breast Cancer Res Treat
Kronen EA, Chervu NL, Ng AP, Lee H, Benharash P, Thompson CK.   +5 more
europepmc   +1 more source

Single-cell transcriptome analysis reveals the malignant characteristics of tumour cells and the immunosuppressive landscape in HER2-positive inflammatory breast cancer. [PDF]

J Exp Clin Cancer Res
Huang J, Zhu Y, Zeng W, Zhang Y, Xia W, Xia F, Liu L, Wang K, Guan Y, Shen T, Jiang B, Sun L, Cao A, Wang S, Li Z.   +14 more
europepmc   +1 more source

Staphylococcus epidermidis biofilm in inflammatory breast cancer and its treatment strategies. [PDF]

Biofilm
Allen-Taylor D, Boro G, Cabato PM, Mai C, Nguyen K, Rijal G.   +5 more
europepmc   +1 more source

HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers. [PDF]

ESMO Open
Lynce F, Martínez-Sáez O, Walbaum B, Brasó-Maristany F, Waks AG, Villagrasa P, Villacampa Javierre G, Sanfeliu E, Galván P, Paré L, Anderson LM, Perou CM, Parker JS, Vivancos A, DiLullo MK, Pernas S, Winer EP, Overmoyer B, Mittendorf EA, Bueno-Muiño C, Martín M, Prat A, Tolaney SM.   +22 more
europepmc   +1 more source

Mutational landscape of inflammatory breast cancer. [PDF]

J Transl Med
Bertucci F, Lerebours F, Ceccarelli M, Guille A, Syed N, Finetti P, Adélaïde J, Van Laere S, Goncalves A, Viens P, Birnbaum D, Mamessier E, Callens C, Bedognetti D.   +13 more
europepmc   +1 more source

Prognostic prediction for inflammatory breast cancer patients using random survival forest modeling. [PDF]

Transl Oncol
Jia Y, Li C, Feng C, Sun S, Cai Y, Yao P, Wei X, Feng Z, Liu Y, Lv W, Wu H, Wu F, Zhang L, Zhang S, Ma X.   +14 more
europepmc   +1 more source